Sample records for tolmetin

  1. The influence of tolmetine on the DNA metabolism

    International Nuclear Information System (INIS)

    Klein, G.; Wottawa, A.; Altmann, H.


    The influence of the antirheumatic drug ''Tolmetin'' on DNA repair has been investigated. ''Tolmetin'' reduces DNA synthesis above a concentration of 100 μg/ml. On the other hand, it does not significantly inhibit any of the repair enzymes exonucleoase, polymerase and ligase. ''Tolmetin'' seems therefore not contraindicated in its use in rheuma therapy. (G.G.)

  2. In vitro release kinetics of Tolmetin from tabletted Eudragit microparticles. (United States)

    Pignatello, R; Consoli, P; Puglisi, G


    In a previous paper the preparation has been described, by three different techniques, of microparticles made of Eudragit RS 100 and RL 100 containing a NSAI agent, Tolmetin. Freely flowing microparticles failed to affect significantly the in vitro drug release, which displayed a similar dissolution profile after micro-encapsulation to the free drug powder. Microparticles were then converted into tablets and the effect of compression on drug delivery, as well as that of the presence of co-additives, was studied in the present work. Furthermore, microparticles were also prepared by adding MgO to the polymer matrix, to reduce the sensitivity of the drug to pH changes during its dissolution. Similarly, magnesium stearate was also used for microparticle formation as a droplet stabilizer, in order to reduce particle size and hinder rapid drug release. A mathematical evaluation, by using two semi-empirical equations, was applied to evaluate the influence of dissolution and diffusion phenomena upon drug release from microparticle tablets.

  3. Preparation and evaluation of tolmetin sodium conventional and sustained-release suppositories


    B., Baloǧlu; O., Kirkaǧaçhoǧlu


    Conventional suppositories of tolmetin sodium were prepared by using two different types of Witepsol as an oily base and two different ratios of polyethylene glycol 400: polyethylene glycol 4000 as an water-soluble base. In addition, sustained- release suppositories were prepared by adding Eudragit L-100 ta the suppositories. The effects of the suppository base and the ratios of the polyethylene glycol 400: polyethylene glycols 4000 on the in vitro release characteristics were investigated. T...

  4. Aspirin and Extended-Release Dipyridamole (United States)

    ... Mobic), nabumetone (Relafen), naproxen (Aleve, Naprosyn), oxaprozin (Daypro), piroxicam (Feldene), rofecoxib (Vioxx) (no longer available in the ... Mobic), nabumetone (Relafen), naproxen (Aleve, Naprosyn), oxaprozin (Daypro), piroxicam (Feldene), sulindac (Clinoril), and tolmetin (Tolectin); phenytoin (Dilantin); ...

  5. Biotechnologies for Assessment of Toxic Hazards in Operational Environments (Utilisation des biotechnologies pour l’evaluation des risques toxiques en environnement operationnel) (United States)


    ibufenac, tolmetin), have been withdrawn from the market because of severe adverse effects in patients, possibly due to antibody formation against...keep existing drugs on the market by identifying subpopulations for whom a drug is beneficial, detrimental, or ineffective. Along with the HapMap...the operation Unicorn (Ivory coast). Lessons learned to improve forces protection Dr. Remy Michel, Inst de Médecine Tropical du Service de Santé des

  6. The influence of API concentration on the roller compaction process: modeling and prediction of the post compacted ribbon, granule and tablet properties using multivariate data analysis. (United States)

    Boersen, Nathan; Carvajal, M Teresa; Morris, Kenneth R; Peck, Garnet E; Pinal, Rodolfo


    While previous research has demonstrated roller compaction operating parameters strongly influence the properties of the final product, a greater emphasis might be placed on the raw material attributes of the formulation. There were two main objectives to this study. First, to assess the effects of different process variables on the properties of the obtained ribbons and downstream granules produced from the rolled compacted ribbons. Second, was to establish if models obtained with formulations of one active pharmaceutical ingredient (API) could predict the properties of similar formulations in terms of the excipients used, but with a different API. Tolmetin and acetaminophen, chosen for their different compaction properties, were roller compacted on Fitzpatrick roller compactor using the same formulation. Models created using tolmetin and tested using acetaminophen. The physical properties of the blends, ribbon, granule and tablet were characterized. Multivariate analysis using partial least squares was used to analyze all data. Multivariate models showed that the operating parameters and raw material attributes were essential in the prediction of ribbon porosity and post-milled particle size. The post compacted ribbon and granule attributes also significantly contributed to the prediction of the tablet tensile strength. Models derived using tolmetin could reasonably predict the ribbon porosity of a second API. After further processing, the post-milled ribbon and granules properties, rather than the physical attributes of the formulation were needed to predict downstream tablet properties. An understanding of the percolation threshold of the formulation significantly improved the predictive ability of the models.

  7. An ibuprofen-antagonized plasmin inhibitor released by human endothelial cells. (United States)

    Rockwell, W B; Ehrlich, H P


    Serum-free culture medium harvested from endothelial cell monolayer cultures derived from human scars and dermis was examined for inhibition of fibrinolysis using a fibrin plate assay. Human cultured fibroblasts and smooth muscle cells did not produce any detectable inhibitory activity. The inhibitor is spontaneously released from the cultured endothelial cells over time. In the fibrin plate assay of plasmin-induced fibrinolysis, one nonsteroidal antiinflammatory (NSAI) drug, ibuprofen, was demonstrated to antagonize the inhibition of fibrinolysis. The antagonistic activity of ibuprofen appears unrelated to its NSAI drug activity because other NSAI drugs such as indomethacin and tolmetin have minimal antagonistic activity. Heating the cultured endothelial cells to 42 degrees C stimulates greater release of the inhibitor in a shorter period of time. This plasmin inhibitor, which is produced by endothelial cells, may contribute to postburn vascular occlusion, leading to secondary progressive necrosis in burn-traumatized patients.

  8. Anti-inflammatory drugs interacting with Zn(II), Cd(II) and Pt(II) metal ions. (United States)

    Dendrinou-Samara, C; Tsotsou, G; Ekateriniadou, L V; Kortsaris, A H; Raptopoulou, C P; Terzis, A; Kyriakidis, D A; Kessissoglou, D P


    Complexes of Zn(II), Cd(II) and Pt(II) metal ions with the anti-inflammatory drugs, 1-methyl-5-(p-toluoyl)-1H-pyrrole-2-acetic acid (Tolmetin), alpha-methyl-4-(2-methylpropyl)benzeneacetic acid (Ibuprofen), 6-methoxy-alpha-methylnaphthalene-2-acetic acid (Naproxen) and 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid (indomethacin) have been synthesized and characterized. In the structurally characterized Cd(naproxen)2 complex the anti-inflammatory drugs acts as bidentate chelate ligand coordinatively bound to metal ions through the deprotonated carboxylate group. Crystal data for 1: [C32H26O8Cd], orthorhombic, space group P22(1)2(1), a = 5.693(2) (A), b = 8.760(3) (A), c = 30.74(1) (A), V = 1533(1) A3, Z = 2. Antibacterial and growth inhibitory activity is higher than that of the parent ligands or the platinum(II) diamine compounds.

  9. Unusual interleukin-1 and -6 expression in fetal cartilage is associated with placental abnormalities.

    Directory of Open Access Journals (Sweden)

    Robert Klepacz


    Full Text Available Unusual expression of interleukin-1alpha, -1beta and -6 was previously found in the epiphyseal cartilage of rat fetuses prenatally exposed to various non-steroidal anti-inflammatory drugs (NSAID, i.e., ibuprofen, piroxicam, tolmetin and selective cyclooxygenase-2 inhibitor (DFU. The aim of the present study was to evaluate the role of placenta in such phenomenon. Morphology of the organ, thickness of basal and labyrinth layer, immunoexpression of COX isoenzymes were examined, and confronted with maternal biochemical data and fetal developmental parameters. Higher maternal urea level, as well as lower placental weight and labyrinth thickness were found in the group of fetuses who revealed expression of genes coded the selected interleukins, when compared with the xenobiotic-exposed pups without the selected genes expression and untreated control. A significant correlation between placental weight and maternal total protein or urea level was revealed. Histological changes like inflammatory infiltration and calcification were observed sporadically. Location and intensity of COX-1 staining was similar in all cases. However, more intense COX-2 staining for majority of cells of the basal zone and in dispersed giant cells of the labyrinth was found in inflamed organs. It could be concluded that abnormal expression of the selected interleukins is associated with low placental weight and decrease of its thickness, especially labyrinth zone, as well as with high maternal urea level.

  10. In Vitro Reactivity of Carboxylic Acid-CoA Thioesters with Glutathione

    DEFF Research Database (Denmark)

    Sidenius, Ulrik; Skonberg, Christian; Olsen, Jørgen


    was to investigate whether a correlation could be found between the structure of acyl-CoA thioesters and their reactivities toward the tripeptide, glutathione (ç- Glu-Cys-Gly).  The  acyl-CoA  thioesters  of  eight  carboxylic  acids  (ibuprofen,  clofibric  acid, indomethacin,  fenbufen,  tolmetin,  salicylic  acid......The chemical reactivity of acyl-CoA thioesters toward nucleophiles has been demonstrated in several recent studies. Thus, intracellularly formed acyl-CoAs of xenobiotic carboxylic acids may react covalently with endogenous proteins and potentially lead to adverse effects. The purpose of this study......,  2-phenoxypropionic  acid,  and  (4-chloro-2-methyl-phenoxy)acetic  acid  (MCPA))  were  synthesized,  and  each  acyl-CoA  (0.5  mM)  was incubated with glutathione (5.0 mM) in 0.1 M potassium phosphate (pH 7.4, 37 °C). All of the acyl-CoAs reacted with glutathione to form the respective acyl...

  11. Magnetite nanoparticles coated with covalently immobilized ionic liquids as a sorbent for extraction of non-steroidal anti-inflammatory drugs from biological fluids

    International Nuclear Information System (INIS)

    Amiri, Maryam; Yadollah, Yamini; Safari, Meysam; Asiabi, Hamid


    Magnetic core-shell nanoparticles (mag-NPs) of type SiO_2-Fe_3O_4 were covalently modified with the ionic liquid dimethyl octadecyl[3-(trimethoxysilyl propyl)]ammonium chloride. The NPs were characterized via FTIR and scanning electron microscopy and evaluated with respect to the extraction of the nonsteroidal anti-inflammatory drugs (NSAIDs) tolmetin, indometacin and naproxen from blood samples. Supercritical fluid extraction was used to eliminate matrix effects before extraction with the mag-NPs. The effects of pH value of sample solution, amount of adsorbent, times of adsorption and desorption, salt effect, type and volume of suitable solvent for desorption were optimized. Under optimum conditions, magnetic solid phase extraction (MSPE) resulted in limits of detection that range between 0.1 and 0.3 μg L"−"1. In case of supercritical fluid extraction along with magnetic solid phase extraction (SFE- MSPE), the LODs ranged from 0.2 to 0.3 mg kg"−"1. The analytical ranges for all of the NSAIDs varied within 0.2–15 mg kg"-"1 and 0.1–250 μg L"−"1 in the SFE-MSPE and MSPE methods, respectively. The relative standard deviations for the extraction of the NSAIDs from blood samples via SFE-MSPE are <10.2%. (author)

  12. Psychopharmacology 2003 Conference, 10-13 September 2003

    Directory of Open Access Journals (Sweden)

    Diana P Morrison


    happens to my medical aid contribution? Eugene Allers 23. Financial issues in a modern private practice Mike Edwards 24. Transcranial magnetic stimulation: Uses in brain function research and medical intervention Alan St Clair Gibson 25. The Neurochemistry of dreams: Implications for Psychiatry Mark Solms 26. Tenascin-R expression in the Central Nervvous system of lower vertebrates Ruth Jarvis, N-. Hsu, P. Pesheva and D.M. Lang 25. Localisation of the Nogo-A receptor in Neronal Lipid rafts Edward Nyatia, D.M. Lang 26. Characterising an animal model for early life trauma using time dependent sensitisation Joachim D.K. Uys, Willie M.U. Daniels, Dan J. Stein 27. Tolmetin affords protection against Quinoclinic acid induced Neurotoxixity in Rat brain Amichand Dairam, S Daya 28. Acetaminophen and aspirin inhibit superoxide anion generation and Lipid Peroxidation, and protect against 1-Methyl-4Phenyl Pyridinim-induced Dopaminergic Neurotoxicity in rats H. Maharaj, D.S. Maharaj, K. S. Saravanan, K.P. Mohanakumar, S. Daya 29. Can exercise provide Neuroprotection in a rat model for Parkinson's disease? M Mabandla, L Kellaway, A St Clair Gibson, M Lambert, V Russell 30. Treatment of rapid cycling Bipolar disorder Joseph R. Calabrese 31. Depression as a Neurodegenerative Disorder: The need for achieving remission Roger M Pinder 32. Side-effects induced by modern antidepressants- Overview and management Franco Colin 33. The Placebo response in antidepressant clinical trials Robin Emsley 34. Impulse control disorders: An overview Donald W. Black 35. Post traumatic stress disorder: The Wits trauma clinic experience Ugash Subramaney 36. Post traumatic stress disorder among recently diagnosed patients with HIV in South Africa Soraya Seedat, Bo Olley, D J Stein 37. Improving outcome in Schizophrenia Diana P Morrison 38. Reviewing post Graduate training Cliff W Allwood 39. Ethics in HIV Research Keimanthro Moodley 40. Improving and maintaining ethical standrads in Psychiatric research